Dirk Jan A. R. Moes at Leiden University Medical Center - Research Interests, Publications & Academic Profile

Dirk Jan A. R. Moes

Leiden University Medical Center

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Vietnamese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

40%

Pharmacology

20%

Pharmacokinetic

30%

Pediatric Hematology

20%

Immunometabolism

20%

Dose Optimization

20%

Immune Response

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Development and Bioequivalence of 3D‐Printed Medication at the Point‐of‐Care: Bridging the Gap Toward Personalized Medicine

Article Link

Year:

2023

Mycophenolic Acid Exposure Determines Antibody Formation Following SARS‐CoV‐2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study

Article Link

Year:

2023

Tacrolimus and Mycophenolic Acid Exposure Are Associated with Biopsy‐Proven Acute Rejection: A Study to Provide Evidence for Longer‐Term Target Ranges

Article Link

Year:

2023

Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients

Article Link

Year:

2023

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study

Article Link

Year:

2023

Monitoring of Ex Vivo Cyclosporin a Activity in Healthy Volunteers Using T Cell Function Assays in Relation to Whole Blood and Cellular Pharmacokinetics

Article Link

Year:

2022

Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study

Article Link

Year:

2022

Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study

Article Link

Year:

2022

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients

Article Link

Year:

2021

Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations

Article Link

Year:

2020

Collaborators9

Robbert Bredius

MD PhD pediatrician & Head residency program

NETHERLANDS

Jacobus Burggraaf

Professor Translational Drug Development

Leiden University Medical Center

NETHERLANDS

Kirsten J. M. Schimmel

NETHERLANDS

Brenda de Winter

Hospital Pharmacist - Assistant Professor

Erasmus University Medical Center

NETHERLANDS

Aiko P. J. de Vries

NETHERLANDS

Henk-Jan Guchelaar

Leiden University Medical Center

NETHERLANDS

Teun van Gelder

Professor in Drug Discovery & Development

Leiden University Medical Center

NETHERLANDS

Arjan Lankester

Head Program Pediatric Stem Cell Transplantation

Leiden University Medical Center

NETHERLANDS

Jesse Swen

Full professor of clinical pharmacy, in particular translational pharmacogenetics

Leiden University Medical Center

NETHERLANDS

How do Vietnamese students reach out?

Meet Kite AI